Pyoderma Gangrenosum – Causes, Symptoms and Treatment
Pyoderma gangrenosum is a rare, inflammatory skin condition that causes painful ulcers. It belongs to the neutrophilic dermatoses and is frequently associated with underlying systemic diseases.
Things worth knowing about "Pyoderma gangrenosum"
Pyoderma gangrenosum is a rare, inflammatory skin condition that causes painful ulcers. It belongs to the neutrophilic dermatoses and is frequently associated with underlying systemic diseases.
What is Pyoderma gangrenosum?
Pyoderma gangrenosum (PG) is a rare, non-infectious, inflammatory skin disorder classified among the neutrophilic dermatoses. These are conditions characterized by an excessive infiltration of neutrophilic granulocytes (a type of white blood cell) into the skin, leading to tissue destruction. The disease typically follows a relapsing course and is marked by rapidly progressing, extremely painful skin ulcers.
Causes and Risk Factors
The exact cause of pyoderma gangrenosum remains incompletely understood. It is considered an autoimmune condition in which the immune system attacks the body's own tissue. A genetic predisposition is likely involved.
In approximately 50–70% of cases, pyoderma gangrenosum is associated with an underlying systemic condition, including:
- Inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis)
- Rheumatoid arthritis and other joint disorders
- Hematological malignancies such as leukemia or monoclonal gammopathy
- Autoimmune diseases such as lupus erythematosus
A key phenomenon in pyoderma gangrenosum is the pathergy reaction: even minor skin injuries or surgical wounds can trigger new ulcers or worsen existing ones.
Symptoms
The typical symptoms of pyoderma gangrenosum often develop rapidly and progress quickly:
- Onset as a small red papule, pustule, or blister
- Rapid progression to a deep, painful ulcer with undermined, violaceous (bluish-red) wound edges
- Severe pain that is often disproportionate to the visible lesion
- Most commonly located on the lower legs, but can also affect the trunk, face, and other areas
- Occasional systemic symptoms such as fever and general malaise
Several clinical variants exist, including the ulcerative (most common), bullous, pustular, and vegetative forms.
Diagnosis
There is no specific laboratory test for pyoderma gangrenosum. The diagnosis is one of exclusion and is based on:
- Clinical presentation and disease course
- Skin biopsy with histological examination (to exclude other causes)
- Exclusion of infections, vascular disorders, malignancies, and other causes of ulceration
- Laboratory tests to identify associated underlying conditions
Diagnostic criteria (e.g., those proposed by Maverakis et al., 2018) can support the diagnostic process.
Treatment
Treatment of pyoderma gangrenosum depends on disease severity and the presence of underlying conditions. The primary goal is to suppress the excessive immune response and promote wound healing.
Local Therapy
- Moist wound care and gentle wound management (avoiding aggressive debridement)
- Topical corticosteroids or calcineurin inhibitors (e.g., tacrolimus) for mild cases
Systemic Therapy
- Corticosteroids (e.g., prednisolone) as first-line therapy in severe cases
- Ciclosporin as an alternative or adjunct immunosuppressant
- Biologics such as TNF-alpha inhibitors (e.g., infliximab, adalimumab), especially for refractory cases or when inflammatory bowel disease is co-present
- Other immunosuppressants including dapsone, azathioprine, or mycophenolate mofetil
Treatment of Underlying Conditions
Managing an associated underlying disease (e.g., Crohn's disease) can positively influence the course of pyoderma gangrenosum and is therefore an essential part of the overall treatment plan.
Prognosis
The course of pyoderma gangrenosum varies greatly between patients. Some respond well to treatment, while others experience a chronic, relapsing course. Even after healing, significant scarring may remain. Close dermatological follow-up and regular monitoring are essential.
References
- Maverakis E. et al. - Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum. JAMA Dermatology, 2018.
- Bolognia J.L., Jorizzo J.L., Schaffer J.V. - Dermatology. 4th Edition, Elsevier, 2018.
- Callen J.P. - Pyoderma gangrenosum. Lancet, 1998; 351(9102): 581–585.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMigraine aura
Filoviridae
Bundibugyo ebolavirus
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Pyoderma gangrenosum-en